Published in J Biol Chem on September 10, 1974
Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature (2009) 2.51
Differential effects of glyphosate and roundup on human placental cells and aromatase. Environ Health Perspect (2005) 1.86
Mechanistic studies on C-19 demethylation in oestrogen biosynthesis. Biochem J (1982) 1.70
Aromatase, aromatase inhibitors, and breast cancer. J Steroid Biochem Mol Biol (2011) 1.36
Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma. Ann Surg (1978) 1.33
What do we know about the mechanisms of aromatase inhibitor resistance? J Steroid Biochem Mol Biol (2006) 1.30
X-ray structure of human aromatase reveals an androgen-specific active site. J Steroid Biochem Mol Biol (2009) 1.18
Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environ Health Perspect (2008) 1.02
Rapid effects of aggressive interactions on aromatase activity and oestradiol in discrete brain regions of wild male white-crowned sparrows. J Neuroendocrinol (2011) 1.02
Letrozole sensitizes breast cancer cells to ionizing radiation. Breast Cancer Res (2004) 1.01
Anti-Müllerian hormone produces endocrine sex reversal of fetal ovaries. Proc Natl Acad Sci U S A (1989) 0.99
Kinetic analysis of the three-step steroid aromatase reaction of human cytochrome P450 19A1. J Biol Chem (2010) 0.99
Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Am J Pathol (1995) 0.97
Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308----Phe, Tyr-361----Phe, Tyr-361----Leu, and Phe-406----Arg. Proc Natl Acad Sci U S A (1991) 0.97
New experimental models for aromatase inhibitor resistance. J Steroid Biochem Mol Biol (2007) 0.96
Human and quail aromatase activity is rapidly and reversibly inhibited by phosphorylating conditions. Endocrinology (2011) 0.94
Aromatase is phosphorylated in situ at serine-118. J Steroid Biochem Mol Biol (2008) 0.89
Isolation and characterization of a complementary DNA specific for human aromatase-system cytochrome P-450 mRNA. Proc Natl Acad Sci U S A (1986) 0.87
Higher order organization of human placental aromatase. Steroids (2011) 0.86
Conversion of a 3-desoxysteroid to 3-desoxyestrogen by human placental aromatase. Proc Natl Acad Sci U S A (1990) 0.85
Update on nandrolone and norsteroids: how endogenous or xenobiotic are these substances? Eur J Appl Physiol (2004) 0.81
Sexual dimorphism of brain aromatase activity in medaka: induction of a female phenotype by estradiol. Environ Health Perspect (2001) 0.81
Conversion of 19-oxo[2 beta-2H]androgens into oestrogens by human placental aromatase. An unexpected stereochemical outcome. Biochem J (1990) 0.79
Selective inhibition of steroidogenic enzymes by ketoconazole in rat ovary cells. Clin Med Insights Reprod Health (2014) 0.79
Source of raised serum estrogens in male rats with portal bypass. J Clin Invest (1988) 0.79
Antiestrogens inhibit xenoestrogen-induced brain aromatase activity but do not prevent xenoestrogen-induced feminization in Japanese medaka (Oryzias latipes). Environ Health Perspect (2006) 0.78
19-Hydroxylation of androgens in the rat brain. Proc Natl Acad Sci U S A (1985) 0.78
Local modulation of steroid action: rapid control of enzymatic activity. Front Neurosci (2015) 0.78
Insight into the binding interactions of CYP450 aromatase inhibitors with their target enzyme: a combined molecular docking and molecular dynamics study. J Mol Model (2011) 0.77
Dynamics and flexibility of human aromatase probed by FTIR and time resolved fluorescence spectroscopy. PLoS One (2013) 0.77
Use of aromatase inhibitors in practice of gynecology. J Ovarian Res (2015) 0.76
5-Azacytidine and sodium butyrate induce expression of aromatase in fibroblasts from chickens carrying the henny feathering trait but not from wild-type chickens. Proc Natl Acad Sci U S A (1985) 0.76
A yeast screen system for aromatase inhibitors and ligands for androgen receptor: yeast cells transformed with aromatase and androgen receptor. Environ Health Perspect (1999) 0.76
Clinical utilities of aromatase inhibitors in breast cancer. Int J Womens Health (2015) 0.76
Aromatase in human common epithelial ovarian neoplasms. Am J Pathol (1996) 0.76
Evidence for an elevated aspartate pK(a) in the active site of human aromatase. J Biol Chem (2014) 0.76
Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase. Biochem J (1998) 0.75
A replication study of a candidate locus for follicle-stimulating hormone levels and association analysis for semen quality traits in Japanese men. J Hum Genet (2016) 0.75
Co-Formulants in Glyphosate-Based Herbicides Disrupt Aromatase Activity in Human Cells below Toxic Levels. Int J Environ Res Public Health (2016) 0.75
DNA methylation within the I.4 promoter region correlates with CYPl19A1 gene expression in human ex vivo mature omental and subcutaneous adipocytes. BMC Med Genet (2013) 0.75
Comprehensive and Automated Linear Interaction Energy Based Binding-Affinity Prediction for Multifarious Cytochrome P450 Aromatase Inhibitors. J Chem Inf Model (2017) 0.75
Exemestane potency is unchanged by common nonsynonymous polymorphisms in CYP19A1: results of a novel anti-aromatase activity assay examining exemestane and its derivatives. Pharmacol Res Perspect (2017) 0.75
Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics (1992) 21.26
A model-based method for identifying species hybrids using multilocus genetic data. Genetics (2002) 8.07
The estimation of pairwise relationships. Ann Hum Genet (1975) 6.87
The SWI/SNF complex and cancer. Oncogene (2009) 5.05
Ascertainment in the sequential sampling of pedigrees. Clin Genet (1977) 4.71
Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science (1999) 4.69
Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med (1978) 4.28
A Monte Carlo method for combined segregation and linkage analysis. Am J Hum Genet (1992) 3.98
MCMC segregation and linkage analysis. Genet Epidemiol (1997) 3.11
Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab (1973) 2.91
Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology (1996) 2.79
Gene identities and multiple relationships. Biometrics (1974) 2.74
The Icelandic admixture problem. Ann Hum Genet (1973) 2.67
Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst (2001) 2.67
Adipose tissue as a source of hormones. Am J Clin Nutr (1987) 2.57
Probability of founder effect in a tribal population. Proc Natl Acad Sci U S A (1978) 2.29
Estimation of age and rate of increase of rare variants. Am J Hum Genet (1976) 2.28
Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man. J Clin Invest (1970) 2.23
Bias in multipoint linkage analysis arising from map misspecification. Genet Epidemiol (2000) 2.21
The checkpoint control for anaphase onset does not monitor excess numbers of spindle poles or bipolar spindle symmetry. J Cell Sci (1997) 2.11
Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol (1978) 2.07
Founder effect and number of private polymorphisms observed in Amerindian tribes. Proc Natl Acad Sci U S A (1978) 2.06
Failure of methotrexate treatment for term placenta percreta. Am J Obstet Gynecol (1994) 2.05
A restriction on the space of genetic relationships. Ann Hum Genet (1976) 2.04
Monte Carlo estimation of variance component models for large complex pedigrees. IMA J Math Appl Med Biol (1991) 2.02
Monte Carlo evaluation of the likelihood for N(e) from temporally spaced samples. Genetics (2000) 1.92
Placental estrogen biosynthesis during human pregnancy. J Clin Endocrinol Metab (1966) 1.92
The serum transport of steroid hormones. Recent Prog Horm Res (1982) 1.91
History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev (2009) 1.88
Disequilibrium likelihoods for fine-scale mapping of a rare allele. Am J Hum Genet (1998) 1.83
Feedback control of the metaphase-anaphase transition in sea urchin zygotes: role of maloriented chromosomes. J Cell Biol (1994) 1.77
Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab (1985) 1.77
Glucocorticoids selectively inhibit translation of ribosomal protein mRNAs in P1798 lymphosarcoma cells. Mol Cell Biol (1987) 1.77
Cloning of a novel phosphatidylinositol kinase-related kinase: characterization of the human SMG-1 RNA surveillance protein. J Biol Chem (2001) 1.74
Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology (1997) 1.67
The placebo-controlled trial as a test of complementary and alternative medicine: observations from research experience of individualised homeopathic treatment. Homeopathy (2004) 1.65
Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab (1974) 1.59
Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer. Oncogene (2008) 1.59
The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem (1974) 1.51
Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab (1974) 1.51
Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog. J Clin Invest (1970) 1.48
Interpretation of LOD scores with a set of marker loci. Genet Epidemiol (1984) 1.45
Glucocorticoid inhibition of initiation of transcription of the DNA encoding rRNA (rDNA) in lymphosarcoma P1798 cells. Proc Natl Acad Sci U S A (1984) 1.45
Delayed androgen treatment prolongs survival in murine lupus. J Clin Invest (1979) 1.43
Hormonal regulation of transcription of rDNA. Purification and characterization of the hormone-regulated transcription factor IC. J Biol Chem (1990) 1.41
The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J Biol Chem (1998) 1.39
Relative weight, weight change, height, and breast cancer risk in Asian-American women. J Natl Cancer Inst (1996) 1.39
Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum (1979) 1.33
Likelihood inference of paternity. Am J Hum Genet (1986) 1.33
A model for the length of tracts of identity by descent in finite random mating populations. Theor Popul Biol (2003) 1.33
Preventing adolescent drug abuse and high school dropout through an intensive school-based social network development program. Am J Health Promot (1994) 1.32
Hormonal regulation of transcription of rDNA. Inhibition of transcription during glucocorticoid-mediated inhibition of proliferation of lymphosarcoma P1798 cells in culture. J Biol Chem (1983) 1.32
Inferring coancestry in population samples in the presence of linkage disequilibrium. Genetics (2012) 1.32
Ancestral inference. I. The problem and the method. Ann Hum Genet (1978) 1.30
Steroid hormones and endometrial cancer. Cancer Res (1978) 1.28
The sense of coherence: an historical and future perspective. Isr J Med Sci (1996) 1.26
Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene (1995) 1.24
The nonequivalence of likelihood and conditional-likelihood solutions in multinomial sampling. Am J Hum Genet (1984) 1.24
Hormonal regulation of transcription of rDNA: glucocorticoid effects upon initiation and elongation in vitro. Nucleic Acids Res (1985) 1.23
Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab (1979) 1.22
Monte Carlo estimation of mixed models for large complex pedigrees. Biometrics (1994) 1.21
The probability distribution of the amount of an individual's genome surviving to the following generation. Genetics (1996) 1.20
Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant? Ann N Y Acad Sci (1977) 1.20
Interobserver variation in ovarian measurements using transvaginal sonography. Gynecol Oncol (1990) 1.20
Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma. Am J Obstet Gynecol (1980) 1.19
Plasma precursors of estrogen. I. Extent of conversion of plasma delta-4-androstenedione to estrone in normal males and nonpregnant normal, castrate and adrenalectomized females. J Clin Endocrinol Metab (1967) 1.19
Maximum likelihood alignment of DNA sequences. J Mol Biol (1986) 1.19
Mechanism of immunosuppression of progesterone on maternal lymphocyte activation during pregnancy. J Immunol (1979) 1.18
The effects of cycloheximide upon transcription of rRNA, 5 S RNA, and tRNA genes. J Biol Chem (1986) 1.17
Massive extranglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy. J Clin Invest (1977) 1.16
Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer (1987) 1.14
Hormonal correlates of 'masculinization' in female spotted hyaenas (Crocuta crocuta). 2. Maternal and fetal steroids. J Reprod Fertil (1992) 1.14
Steroids as immunosuppressants in pregnancy. Immunol Rev (1983) 1.14
Estrogen receptors and the estrone hypothesis in relation to endometrial and breast cancer. Gynecol Oncol (1974) 1.14
Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4. J Biol Chem (1986) 1.13
Possible linkage of a breast cancer-susceptibility locus to the ABO locus: sensitivity of LOD scores to a single new recombinant observation. Genet Epidemiol (1984) 1.13
Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT. Oncogene (2006) 1.13
Transfection of mouse ribosomal DNA into rat cells: faithful transcription and processing. Nucleic Acids Res (1985) 1.12
Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle. Cell Growth Differ (1996) 1.12
Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol (1996) 1.11
Distribution of genome shared IBD by half-sibs: approximation by the Poisson clumping heuristic. Theor Popul Biol (1996) 1.11
Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J Biol Chem (1980) 1.11
Preparation and certain properties of highly purified streptokinase. J Biol Chem (1967) 1.09
Linkage analysis and the inheritance of arches in a Habbanite isolate. Am J Hum Genet (1979) 1.09
Transvaginal sonography as a screening method for ovarian cancer. A report of the first 1000 cases screened. Cancer (1990) 1.08
Sampling schemes and ascertainment. Prog Clin Biol Res (1979) 1.08
Immunologic and endocrine interrelationships in pregnancy. Biol Reprod (1982) 1.08
Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone. Cancer Epidemiol Biomarkers Prev (1996) 1.07
Field calibration unit for ultraviolet spectroradiometers. Appl Opt (1998) 1.07
Linkage disequilibrium mapping: the role of population history, size, and structure. Adv Genet (2001) 1.07
Hormonal regulation of transcription of rDNA. Formation of initiated complexes by RNA polymerase I in vitro. J Biol Chem (1990) 1.06
Prevention research program: reconnecting at-risk youth. Issues Ment Health Nurs (1994) 1.06
Reducing suicide potential among high-risk youth: tests of a school-based prevention program. Suicide Life Threat Behav (1995) 1.06
Culture, ethnicity, and the family: critical factors in childhood chronic illnesses and disabilities. Pediatrics (1993) 1.05
Human cytomegalovirus infection results in altered Cdk2 subcellular localization. J Gen Virol (1997) 1.04
TGF-beta1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression. Oncogene (1998) 1.04
Hormonal regulation of transcription of rDNA. The role of TFIC in formation of initiation complexes. J Biol Chem (1990) 1.04
The Drug Involvement Scale for Adolescents (DISA). J Drug Educ (1996) 1.03
Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst (1987) 1.02